Braveheart Bio, Inc. (BRVE) vs Zenas BioPharma, Inc. (ZBIO)
- Braveheart Bio, Inc. BRVE 19.62 −4.29%
- Zenas BioPharma, Inc. ZBIO 28.01 +1.34%
Braveheart Bio, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Braveheart Bio, Inc. and Zenas BioPharma, Inc. are of similar size ($1.9B and $1.8B). Braveheart Bio, Inc. has the higher net margin (0.00% vs −763.1%) and the lower return on invested capital (−28.7% vs 0.00%). Across the 12 metrics below, Braveheart Bio, Inc. leads on 8 and Zenas BioPharma, Inc. on 4.
Valuation
Profitability
| Metric | BRVE | ZBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 67.24% |
| Operating margin | 0.00% | (741.41%) | 0.00% |
| Net margin | 0.00% | (763.11%) | 0.00% |
| Free cash flow margin | 0.00% | (342.02%) | 0.00% |
| Return on equity | 0.00% | (265.11%) | (50.28%) |
| Return on assets | 0.00% | (108.66%) | (45.89%) |
| Return on invested capital | (28.66%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack